Vasogenic erectile dysfunction Topiramate-induced

Clin Neurol Neurosurg. 2012 Jan;114(1):70-1. doi: 10.1016/j.clineuro.2011.07.018. Epub 2011 Aug 24.

Abstract

Reversible erectile dysfunction due to Topiramate has been linked to the effect of this antiepileptic drug on reproductive hormones levels. We described two epileptic male patients which experienced erectile dysfunction during Topiramate treatment. Serum sexual hormones were tested during treatment and at several time intervals following drug discontinuation. Topiramate did not seem to affect plasma levels of total, free and bioavailable testosterone and sex hormone-binding globulin. Since Topiramate erectile dysfunctions could not be related to changes in reproductive hormones levels, a vasogenic mechanism must be considered.

Publication types

  • Case Reports

MeSH terms

  • Adult
  • Androgens / blood
  • Anticonvulsants / adverse effects*
  • Anticonvulsants / therapeutic use
  • Epilepsy, Complex Partial / complications
  • Epilepsy, Complex Partial / drug therapy
  • Epilepsy, Temporal Lobe / complications
  • Epilepsy, Temporal Lobe / drug therapy
  • Fructose / adverse effects
  • Fructose / analogs & derivatives*
  • Fructose / therapeutic use
  • Gonadal Steroid Hormones / blood
  • Humans
  • Impotence, Vasculogenic / chemically induced*
  • Impotence, Vasculogenic / etiology
  • Luteinizing Hormone / blood
  • Magnetic Resonance Imaging
  • Male
  • Middle Aged
  • Penis / blood supply
  • Regional Blood Flow / drug effects
  • Sex Hormone-Binding Globulin
  • Testosterone / blood
  • Topiramate

Substances

  • Androgens
  • Anticonvulsants
  • Gonadal Steroid Hormones
  • Sex Hormone-Binding Globulin
  • Topiramate
  • Fructose
  • Testosterone
  • Luteinizing Hormone